Neodymium Magnetic Bead Ingestion in a Toddler

od Hui, Kenneth J., Arasu, Vignesh A., Vinson, David R., Cotton, Dale M.
Wydane w Perm J (2020)

Acute Kidney Injury After CT in Emergency Patients with Chronic Kidney Disease: A Propensity Score-matched Analysis

od Kene, Mamata, Arasu, Vignesh A., Mahapatra, Ajit K., Huang, Jie, Reed, Mary E.
Wydane w West J Emerg Med (2021)

Diagnostic Emergency Imaging Utilization at an Academic Trauma Center From 1996 to 2012

od Arasu, Vignesh A., Abujudeh, Hani H., Biddinger, Paul D., Noble, Vicki E., Halpern, Elkan F., Thrall, James H., Novelline, Robert A.
Wydane w J Am Coll Radiol (2015)

Can Signal Enhancement Ratio (SER) Reduce the Number of Recommended Biopsies without Affecting Cancer Yield in Occult MRI-detected Lesions?

od Arasu, Vignesh A., Chen, Ryan C-Y., Newitt, David N., Chang, C. Belinda, Tso, Hilda, Hylton, Nola M., Joe, Bonnie N.
Wydane w Acad Radiol (2011)

Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices

od Ray, Kimberly M., Kerlikowske, Karla, Lobach, Iryna V., Hofmann, Michael B., Greenwood, Heather I., Arasu, Vignesh A., Hylton, Nola M., Joe, Bonnie N.
Wydane w Radiology (2018)

Benefit of Semiannual Ipsilateral Mammographic Surveillance Following Breast Conservation Therapy

od Arasu, Vignesh A., Joe, Bonnie N., Lvoff, Natalya M., Leung, Jessica W.T., Brenner, R. James, Flowers, Chris I., Moore, Dan H., Sickles, Edward A.
Wydane 2012

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL

od Li, Wen, Arasu, Vignesh, Newitt, David C., Jones, Ella F., Wilmes, Lisa, Gibbs, Jessica, Kornak, John, Joe, Bonnie N., Esserman, Laura J., Hylton, Nola M.
Wydane w Tomography (2016)

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial

od Onishi, Natsuko, Li, Wen, Gibbs, Jessica, Wilmes, Lisa J., Nguyen, Alex, Jones, Ella F., Arasu, Vignesh, Kornak, John, Joe, Bonnie N., Esserman, Laura J., Newitt, David C., Hylton, Nola M.
Wydane w Tomography (2020)

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy

od Nguyen, Alex Anh-Tu, Arasu, Vignesh A., Strand, Fredrik, Li, Wen, Onishi, Natsuko, Gibbs, Jessica, Jones, Ella F., Joe, Bonnie N., Esserman, Laura J., Newitt, David C., Hylton, Nola M.
Wydane w Tomography (2020)

Additive value of diffusion weighted MRI in the I-SPY 2 TRIAL

od Li, Wen, Newitt, David C., Wilmes, Lisa J., Jones, Ella F., Arasu, Vignesh, Gibbs, Jessica, Yun, Bo La, Li, Elizabeth, Partridge, Savannah C., Kornak, John, Esserman, Laura J., Hylton, Nola M.
Wydane w J Magn Reson Imaging (2019)

Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2− Patients

od Arasu, Vignesh A, Kim, Paul, Li, Wen, Strand, Fredrik, McHargue, Cody, Harnish, Roy, Newitt, David C, Jones, Ella F, Glymour, M Maria, Kornak, John, Esserman, Laura J, Hylton, Nola M
Wydane w J Breast Imaging (2020)

Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer

od Li, Wen, Newitt, David C., Yun, Bo La, Jones, Ella F., Arasu, Vignesh, Wilmes, Lisa J., Gibbs, Jessica, Nguyen, Alex Anh-Tu, Onishi, Natsuko, Kornak, John, Joe, Bonnie N., Esserman, Laura J., Hylton, Nola M.
Wydane w Tomography (2020)

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

od Huang, Shih-ying, Franc, Benjamin L., Harnish, Roy J., Liu, Gengbo, Mitra, Debasis, Copeland, Timothy P., Arasu, Vignesh A., Kornak, John, Jones, Ella F., Behr, Spencer C., Hylton, Nola M., Price, Elissa R., Esserman, Laura, Seo, Youngho
Wydane w NPJ Breast Cancer (2018)

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk

od Arasu, Vignesh A., Miglioretti, Diana L., Sprague, Brian L., Alsheik, Nila H., Buist, Diana S.M., Henderson, Louise M., Herschorn, Sally D., Lee, Janie M., Onega, Tracy, Rauscher, Garth H., Wernli, Karen J., Lehman, Constance D., Kerlikowske, Karla
Wydane w J Clin Oncol (2019)

Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL

od Li, Wen, Newitt, David C., Gibbs, Jessica, Wilmes, Lisa J., Jones, Ella F., Arasu, Vignesh A., Strand, Fredrik, Onishi, Natsuko, Nguyen, Alex Anh-Tu, Kornak, John, Joe, Bonnie N., Price, Elissa R., Ojeda-Fournier, Haydee, Eghtedari, Mohammad, Zamora, Kathryn W., Woodard, Stefanie A., Umphrey, Heidi, Bernreuter, Wanda, Nelson, Michael, Church, An Ly, Bolan, Patrick, Kuritza, Theresa, Ward, Kathleen, Morley, Kevin, Wolverton, Dulcy, Fountain, Kelly, Lopez-Paniagua, Dan, Hardesty, Lara, Brandt, Kathy, McDonald, Elizabeth S., Rosen, Mark, Kontos, Despina, Abe, Hiroyuki, Sheth, Deepa, Crane, Erin P., Dillis, Charlotte, Sheth, Pulin, Hovanessian-Larsen, Linda, Bang, Dae Hee, Porter, Bruce, Oh, Karen Y., Jafarian, Neda, Tudorica, Alina, Niell, Bethany L., Drukteinis, Jennifer, Newell, Mary S., Cohen, Michael A., Giurescu, Marina, Berman, Elise, Lehman, Constance, Partridge, Savannah C., Fitzpatrick, Kimberly A., Borders, Marisa H., Yang, Wei T., Dogan, Basak, Goudreau, Sally, Chenevert, Thomas, Yau, Christina, DeMichele, Angela, Berry, Don, Esserman, Laura J., Hylton, Nola M.
Wydane w NPJ Breast Cancer (2020)